Group Psilocybin-assisted Cognitive Behavioral Therapy for Major Depressive Disorder
This study will seek to determine the (1) acceptability and (2) feasibility of psilocybin as an adjunct to cognitive-behavioral therapy, delivered as a group treatment (G-PACBT) for major depressive disorder and (3) explore the clinical effects of G-PACBT on depressive symptoms and psychosocial functioning.
- Status
- planned
- Phase
- Phase 2
- Institution
- University of California, Los Angeles
- Start date
- 2027-01-01
- End date
- 2028-12-01
- Registry ID
- NCT07566104
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.